Trial · NCT01087788
Participant flow39
How many started, completed or left each group, period by period.
1 to 20 of 39
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 24-weeks Double-blind Period | STARTED | Placebo | 136 | |
| 24-weeks Double-blind Period | STARTED | CZP 200 mg Q2W | 138 | |
| 24-weeks Double-blind Period | STARTED | CZP 400 mg Q4W | 135 | |
| 24-weeks Double-blind Period | Received CZP 200 mg Q2W at 16 Weeks | Placebo | 30 | |
| 24-weeks Double-blind Period | Received CZP 200 mg Q2W at 16 Weeks | CZP 200 mg Q2W | 0 | |
| 24-weeks Double-blind Period | Received CZP 200 mg Q2W at 16 Weeks | CZP 400 mg Q4W | 0 | |
| 24-weeks Double-blind Period | Received CZP 400 mg Q4W at 16 Weeks | Placebo | 29 | |
| 24-weeks Double-blind Period | Received CZP 400 mg Q4W at 16 Weeks | CZP 200 mg Q2W | 0 | |
| 24-weeks Double-blind Period | Received CZP 400 mg Q4W at 16 Weeks | CZP 400 mg Q4W | 0 | |
| 24-weeks Double-blind Period | COMPLETED | Placebo | 120 | |
| 24-weeks Double-blind Period | COMPLETED | CZP 200 mg Q2W | 128 | |
| 24-weeks Double-blind Period | COMPLETED | CZP 400 mg Q4W | 120 | |
| 24-weeks Double-blind Period | NOT COMPLETED | Placebo | 16 | |
| 24-weeks Double-blind Period | NOT COMPLETED | CZP 200 mg Q2W | 10 | |
| 24-weeks Double-blind Period | NOT COMPLETED | CZP 400 mg Q4W | 15 | |
| 24-weeks Dose-blind Period | STARTED | Placebo | 120 | |
| 24-weeks Dose-blind Period | STARTED | CZP 200 mg Q2W | 128 | |
| 24-weeks Dose-blind Period | STARTED | CZP 400 mg Q4W | 120 | |
| 24-weeks Dose-blind Period | Received CZP 200 mg Q2W at 24 Weeks | Placebo | 60 | |
| 24-weeks Dose-blind Period | Received CZP 200 mg Q2W at 24 Weeks | CZP 200 mg Q2W | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01087788/flow